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Storage using BDM or Blebbistatin Preserves Functional Measures of
Unloaded Cardiomyocytes
Charles S. Chung, Charles Mechas, Kenneth S. Campbell.
University of Kentucky, Lexington, KY, USA.
Intact isolated cardiomyocytes are used to investigate the molecular mecha-
nisms of contraction and to screen new therapeutic compounds. Typically,
these studies require either daily isolation or culture of cardiomyocytes, which
either costs investigators time and animals or alters myocyte function and
morphology. Recently, investigators reported preserving canine cardiomyocyte
function using N-benzyl-p-toluene sulphonamide (BTS), a skeletal muscle
myosin ATPase inhibitor. We investigated the preservation of rat cardiomyo-
cyte function using the common cardiac cross-bridge inhibitors 2,3-Butane-
dione monoxime (BDM), a phosphatase, and Blebbistatin, a selective myosin
ATPase. We isolated cardiomyocytes from 6 mo old female Sprague Dawley
rats. The isolate was divided for use over multiple days and storage conditions.
Functional measurements (calcium transients and sarcomere length (SL)
twitches) were obtained in a Tyrodes solution at 25C beginning on the day
of isolation (Day 0). Cells used on Days 1-4 post isolation were stored in a
HEPES buffered solution with 0.5mM Cat(2þ) at 4C: (1) without additional
cross-bridge inhibitors (control), (2) þ10mM BDM, and (3) þ3mM Blebbista-
tin. Control (inhibition-free) cells showed reduced SL (<1.7mm diastolic),
membrane blebbing, and altered functional measurements (calcium transients
and SL twitches) within 24 hours. Cells stored in BDM maintained function
for 24 hours but exhibited reduced diastolic SL and significant blebbing at
48 hours. Cells stored in blebbistatin showed excellent maintenance of diastolic
SL and cell membrane quality more than 4 days post isolation. Calcium tran-
sients did not change after 4 days of storage in blebbistatin, but SL shortening
was attenuated after 24 hrs. UV light exposure deactivated blebbistatin inhibi-
tion and restored SL shortening back to Day 0 magnitudes. Storage of rodent
cardiomyocytes may help investigators reduce, replace, or refine experiments
by allowing extended use of cardiomyocytes from single isolations.
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Rapid, High Efficience Purification of Myofilament Proteins using Tobacco
Etch Virus Protease
Mengjie Zhang, Jody L. Martin, Pieter P. De Tombe, Ramzi J. Khairallah.
Cell and Molecular Physiology, Loyola University Chicago, Maywood, IL,
USA.
As more and more cardiomyopathy causing mutations are identified, functional
studies investigating contractility and myofilament mechanics with mutated
proteins become more crucial. Several methods are available, but most rely
on exchanging recombinant protein into permeabilized heart cells or myofila-
ment preparation. However, success requires large amounts of highly purified
myofilament proteins, a process which is usually different for each individual
protein. Here, we describe one single method that can be used for purifying
myofilament protein, including troponin T, I and C, as well as myosin light
chain 2, which has also been adapted to other recombinant proteins. We fuse
a HIS-tag and a modified tobacco etch virus (TEV) protease cleavage site, EN-
LYFQ/M, to the N- terminal of our protein construct. The flexibility of P1’ res-
idue of the TEV protease cleavage site allows substitution of the native glycine
to a methionine, enabling production of unmodified forms of protein after pu-
rification. We then express recombinant protein constructs in BL21 (DE3)
E.coli competent cells which are lysed in buffer containing 6 M Urea. Clarified
lysate is then applied to a HisTrap nickel affinity column. Following a low con-
centration of imidazole wash, the protein is then eluted with high imidazole,
and the elution buffer is replaced by a high salt protease digestion buffer using
a desalting column. Protease digestion is performed at 4C overnight, and any
undigested protein and the protease itself are removed by a second run on a Hi-
sTrap, allowing the purified recombinant protein to be collected. A final desalt-
ing step allows us to store the protein in a variety of solutions according to
experimental needs. Overall, this method significantly increases yield and ac-
celerates purification process from almost a week to only two days.
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Structural Effects of Cardiac Troponin T R92L and Tropomyosin D230N
Mutants in the Cardiac Thin Filament
Mark T. McConnell1, Lauren Grinspan2, Jil Tardiff3.
1Biomedical Engineering, University of Arizona, Tucson, AZ, USA,
2Physiology and Biophysics, Albert Einstein College of Medicine, Bronx,
NY, USA, 3Cellular and Molecular Medicine, University of Arizona, Tucson,
AZ, USA.
Introduction/Methods: Inherited mutations in cardiac thin filament proteins
lead to changes in protein structure and dynamics. This results in the pathological
tissue remodeling seen in patients with hypertrophic (HCM) and dilated (DCM)cardiomyopathies. Our group is interested in the alpha-Tm D230N mutation
known to cause DCM and the cardiac troponin T (cTnT) mutation R92L which
causes HCM. To investigate effects of these mutations on the tropomyosin (Tm)
head-to-tail overlap we used Forster Resonance Energy Transfer (FRET). For
both wild-type and mutants, Tm was labeled at site 271 with DDPM, cTnT
was labeled with IAEDANS at site 100. Labeled cTnT was reconstituted into
troponin complex (Tn) and combined with Tm along with actin to form the re-
constituted thin filament. Time-resolved data was acquired and analyzed.
Results/Conclusions: Both R92L and D230Nmutants result in a change in dis-
tance between labeled sites of cTnT andTmwhen compared towild-type. Trans-
fer efficiency decreased from 0.78 to 0.66 upon addition of the D230Nmutation,
representing an increased distance between the labeled sites. However, the trans-
fer efficiency increased from 0.78 to 0.80 in the presence of the R92L mutation,
supporting a decreased distance between the labeled sites. This differentialmod-
ulation of the distancemay reflect alterations in the interaction between the cTnT
and Tm proteins due to these mutations. This supports the hypothesis that these
mutations which cause different clinical phenotypes are having opposite effects
in the region of interest. Ongoing experiments utilizing site 60 of cTnT, and sites
262 and 279 of Tmwill provide additional information about the similar and dif-
ferential effects of these mutants on the Tm overlap region.
1479-Pos Board B430
Contractile Properties of Myofibrils from hiPSC-Derived Cardiomyocytes
of Patients with Duchenne Muscular Dystrophy
Jose` Manuel Pioner1,2, Alice Ward Racca2, Xuan Guan3, Lil Pabon4,
Mark Y. Jeong5, Christian I. Childers6, Jesse Macadangdang2,
Veronica Muskheli4, Corrado Poggesi1, Deok-Ho Kim2, David L. Mack3,
Martin K. Childers3, Charles E. Murry4, Michael Regnier2.
1Experimental and Clinical Medicine, University of Florence, Florence, Italy,
2Bioengineering, University of Washington, Seattle, WA, USA,
3Rehabilitation Medicine, University of Washington, Seattle, WA, USA,
4Pathology, University of Washington, Seattle, WA, USA, 5Medicine (Div.
Cardiology), University of Colorado, Denver, CO, USA, 6University of
Washington, Seattle, WA, USA.
Duchenne Muscular Dystrophy (DMD) is a wasting disease of striated muscle
resulting from membrane fragility. We modeled DMD cardiac disease using
urine-derived cells from a patient, reprogrammed to induced pluripotent stem
cells (hiPSCs) and differentiated into cardiomyocytes (DMD-hiPSC-CMs).
DMD-hiPSC-CMs were dystrophin-deficient (exon 50 deletion) and manifested
physiological consequences of the disease such as calcium-handling abnormal-
ities. Here we report, for the first time, isolation and functional characterization
of myofibrils from hiPSC-CMs to study DMD cardiomyopathy.
At day 20 post-differentiation, DMD-hiPSC-CMs and control hiPSC-CMs (from
a healthy volunteer) were replated onto fibronectin-coated nanopatterned cover-
slides and cultured until day 80. Both DMD- and controls-CMs exhibited more
mature morphology with aligned myofibrils and clearly defined Z-bands, cell
lengths of 100-150mm and widths of 40mm. For mechanical measurements, cells
were harvested and skinned in a rigor solution containingTriton 1%for 5minutes.
Control hiPSC-CM myofibrils had mechanical and kinetic proporties more
similar to human fetal skeletal (Racca, 2013) or cardiac myofibrils than human
adult cardiac myofibrils. Preliminary data for DMD-hiPSC-CMs showed lower
force development, prolonged duration of early, slow phase relaxation kinetics
(tREL slow), but no differences in the other kinetic properties. Preliminary data
from intact DMD-hiPSC-CMs paced at 1Hz showed no difference in the rate
of cell shortening, but depressed magnitude and prolonged relaxation (t50).
We previously reported (Xuan G, 2014) prolongation of Ca2þ transient decay.
Together these data suggest DMD-hiPSC-CMs have slower relaxation due to
both myofibril properties and Ca2þ sequestration, compared with control
hiPSC-CMs, and both cell lines have myofibril mechanic and kinetic properties
more similar to fetal than adult myofibrils.
In conclusion, we demonstrated that isolated functional myofibrils from hiPSC-
CMs can be obtained after growing on nano-patterned surfaces in culture to
study cardiac diseases in vitro.Smooth Muscle Mechanics, Structure, and
Regulation
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AFM Reveals Age-Dependent Micromechanical Degradation of Cardio-
pulmonary Tissues in a Mouse Model of Marfan Syndrome
Jia-Jye Lee1,2, Satish Rao1, Josephine Galatioto3, Francesco Ramirez3,
Kevin D. Costa1.
1Cardiovascular Research Center, Icahn School of Medicine at Mount Sinai,
New York, NY, USA, 2Department of Biomedical Engineering, The City
296a Monday, February 9, 2015College of New York, New York, NY, USA, 3Department of Pharmacology
and Systems Therapeutics, Icahn School of Medicine at Mount Sinai, New
York, NY, USA.
Marfan syndrome (MFS) is caused by mutation of the FBN1 gene encoding the
extracellular matrix (ECM) protein fibrillin-1 that forms elastic microfibrils.
This study aims to characterize the micromechanics of aortic and lung tissues
from wild type (WT) and FBN1-deficient mutant (MT) mice to identify bio-
physical determinants of cardiopulmonary disease in MFS. For testing by
atomic force microscopy (AFM), full-thickness sections of ascending aorta
were dissected from young (0.5-mo) and adult (2-mo) WT and MT mice,
mounted flat with the lumen facing up, and indented with a 15-mm spherical
probe at 3-5 sites per sample from 1-4 animals per condition. Indentation
force-depth curves were analyzed using a hybrid theoretical and finite element
analysis to determine the elastic modulus of intima (Eint) and media (Emed)
layers. The Kolmogorov-Smirnov test was performed for pairwise statistical
analysis; p<0.008 was considered significant based on the Bonferroni correc-
tion. Emed at 0.5-mo showed no difference between WT (10.152.7kPa, n¼8;
mean5SEM for n-curves) and MT (7.550.6kPa, n¼80). Emed increased
with age (p<0.0006), but was significantly softer in MT (21.351.4kPa,
n¼112) vs WT (37.452.2kPa, n¼65, p<0.0001). Eint also increased with
age (p<0.003) from ~2kPa to ~5-10kPa, but showed no significant difference
between WT and MT at matched ages. Similar nano-indentation studies, using
a pyramidal probe on lung parenchyma isolated from 2-mo WT and MT mice,
showed Elung for MT (1.750.1 kPa, n¼92) was significantly softer than WT
(4.850.3kPa, n¼91, p<0.0001). In conclusion, AFM revealed age-
dependent softening of micro-elastic modulus in elastin-rich tissues including
lung parenchyma and aortic media, but not in the aortic intima. In contrast to
macro-scale measurements of aortic stiffening in MFS, these micro-scale
AFM findings appear consistent with histological observations of local disrup-
tion of ECM microstructure in MFS.
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Bronchial but not Tracheal Smooth Muscle is Hypercontractile in an
Equine Model of Severe Asthma
Oleg S. Matusovsky1, Linda Kachmar1, Gijs Ipgma1, Nedjma Zitouni1,
Genevieve Bates1, Jean-Pierre Lavoie2, Anne-Marie Lauzon1.
1Faculty of Medicine, McGill University, Montreal, QC, Canada, 2Faculty of
Veterinary Medicine, University of Montreal, Montreal, QC, Canada.
Asthma is an inflammatory disease of the airways characterized by airway hy-
perresponsiveness, an exaggerated bronchoconstrictive response of airway
smooth muscle (ASM) to stimuli. However, whether asthmatic ASM is me-
chanically different from non-asthmatic ASM is still unclear. Most studies so
far have been performed on the trachealis muscle but it might not be represen-
tative of smooth muscle in the more peripheral airways. Thus, we addressed
this question in an equine model of asthma (horse with heaves) and compared
the trachealis (TSM) and peripheral bronchial (BSM) airway smooth muscle
mechanics.
Muscle strips from de-epithelialized TSM and BSM (less than 10 mm in diam-
eter) were mounted horizontally in an experimental chamber between a length
controller and a force transducer (Aurora Scientific Inc.). Maximal velocity of
shortening (Vmax), methacholine dose response and stress were measured.
We found no difference in Vmax between TSM from control horses and horses
with heaves (0.12450.01vs. 0.11950.01; control vs. heaves; P¼0.8), whereas
the BSM exhibited a significantly higher Vmax (0.11450.01 vs. 0.23950.02;
P¼0.03). Western blot analysis showed a significant increase of the (þ)insert
fast smooth muscle myosin heavy chain (SMMHC) isoform in BSM of
heaves-affected horses (0.7850.04 vs. 1.050.05, P¼0.0092), while no such
difference was found in TSM (0.9150.05 vs.0.9750.08;P¼0.54). The expres-
sion of calponin was significantly increased in TSM of heaves-affected horses
(0.9250.15 vs. 2.550.57, P¼0.037; but this was not observed in BSM
(0.3750.14 vs. 0.4950.18; P¼0.62). There were no differences detected in
the expression of MLCK, total SMMHC and transgelin. Peripheral airways
may have a greater exposure to inflammatory cells than the trachealis which
may explain their differences in mechanics. Further studies await to determine
the mechanism underlying in observed effect.
Supported by: CIHR(MOP102718), NIH(RO1HL103405), RFBR(12-04-0076)
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Redefining the Latch-State in Human Airway Smooth Muscle
Gijs Ijpma, Linda Kachmar, Anne-Marie Lauzon.
Meakins-Christie Laboratories, McGill University, Outremont, QC, Canada.
Rationale: The latch-state describes the ability of tonic smooth muscle to main-
tain force at reduced ATP consumption and crossbridge cycling rate. In animal
models this is evidenced by reduced unloaded shortening velocity (Vmax), pre-
sumably indicative of crossbridge cycling rate, and reduced myosin light chainphosphorylation (pMLC). In this study we aim to assess this phenomenon in
human airway smooth muscle (hASM).
Methods: hASM tissues were dissected from trachea procured from the Inter-
national Institute for the Advancement of Medicine. Force-velocity curves
and pMLC measurements were performed at several time points in multiple
prolonged methacholine 10-6M contractions. Rat ASM strips were tested
with the same protocol. A mathematical model was developed to explain the
findings.
Results: Despite a 40% drop in pMLC between the 1st to the 20th min after the
peak contraction, hASM Vmax did not show any change. Conversely, rat ASM
Vmax decreased by 50%. A mathematical model of the cross-bridge cycle,
combining strain-dependent ADP affinity of myosin with actin regulated bind-
ing of dephosphorylated myosin heads, was capable of reproducing our
findings.
Conclusion: As our results contradict the classical latch-bridge theory, we
suggest an alternative model. We propose that Vmax, as calculated from
standard force-velocity curves, is not indicative of the crossbridge cycling
rate during latch. Instead, Vmax is reduced due to drag caused by dephos-
phorylated myosin heads binding to actin, with their binding force regulated
by actin regulatory proteins and their activation state. The increase in de-
phosphorylated myosin late in contraction decreases the measured Vmax,
unless its binding force is down-regulated by regulatory proteins. Our
modelling further shows that force maintenance can be explained by phos-
phorylated myosin heads remaining attached to actin in a locked configura-
tion, unable to release ADP because of strain dependence of the ADP affinity
of myosin.
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Kinetic Characterization of Stabilized Smooth Muscle Myosin Filaments
Brian D. Haldeman, Christine Cremo, Josh Baker.
Biochemistry, University of Nevada, Reno, Reno, NV, USA.
We have measured kinetic parameters of smooth muscle myosin (SMM) fila-
ment interactions with actin, ADP, and ATP using stopped-flow fluorimetry.
Our objective was to determine which parameters, if any, are different from
those of monomeric myosins, S1 and HMM, using buffers at physiologic
ionic strength. Previously we measured the ATP-dependence of SMM fila-
ment velocities (using EDC-cross-linked filaments that are stable to ATP-
induced depolymerization) in an inverted in vitro motility assay with myosin
filaments moving over surface-attached actin. We compared this to the
ATP-dependence of solution actin-activated ATPase measurements. The
two relationships are very similar, suggesting that they are both attachment-
limited and regulated by the same kinetic step, presumably phosphate release
(Haldeman et al JBC 2014). This is in contrast to the kinetics of actin moving
over a surface of monomeric SMM (standard vitro motility assay), known to
be predominately detachment-limited, limited by ADP release. We hypothe-
sized that heads within moving filaments are attached to unhindered and
thus flexible S2 regions putting minimal strain on heads put in the drag posi-
tion. In contrast, the S2 region of monomeric myosin is bound to the surface
and not as flexible allowing the relative stiff head domains to become strained,
which affects the underlying kinetics of acto-SMM interactions. All kinetic
parameters measured so far in solution for myosin or acto-myosin, ADP asso-
ciation, ADP dissociation, ATP binding, ATP-induced dissociation, and acto-
myosin affinity, are very similar to those for S1 and HMM. Measurements of
Pi release kinetics by limited turnover are planned. If Pi release kinetics is
also similar, this will suggest that the attachment-limited kinetics that is
unique to filaments is not due to alterations in any fundamental kinetic param-
eters, but instead is due to differences in the effective head or head/S2 stiff-
ness during the assays.
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Varying the Number of Heads in Phosphorylated Smooth Muscle Myosin
Filaments Provides Evidence for Attachment Limited Kinetics of in vitro
Actin-Sliding Velocities
Richard Brizendine, Diego Alcala, Brian Haldeman, Kevin Facemyer,
Josh Baker, Christine Cremo.
Department of Biochemistry and Molecular Biology, University of Nevada,
Reno, NV, USA.
Previously we have shown that the ATP-dependence of EDC-stabilized fluo-
rescent smooth muscle myosin (SMM) filament motility is very similar to so-
lution ATPase values (KATP ¼ 8.5 and 9.2 mM, respectively). This suggests
both processes are influenced by the same kinetic step, acto-myosin attach-
ment not detachment, presumably linked to Pi release. This mechanism pre-
dicts that velocities will be linearly related to the number of working heads.
Therefore, we prepared SMM- rod co-filaments that contain fewer molecules
per filament length as well as longer SMM filaments that contain more
